sub:assertion {
d:DB00376 dv:ddi-interactor-in dr:DB00376_DB00761 .
d:DB00761 dv:ddi-interactor-in dr:DB00376_DB00761 .
dr:DB00376_DB00761 dct:identifier "drugbank_resource:DB00376_DB00761" ;
dct:title "DDI between Trihexyphenidyl and Potassium Chloride - The ulcerative effects of solid oral dosage forms of KCl may be enhanced by Trihexyphenidyl, an anticholinergic. Anticholinergics slow gastric emptying, increasing the contact time between the gastrointestinal mucosa and KCl. Prolonged exposure to KCl increases the risk of gastric and intestinal irritation and ulceration. Solid oral dosage forms of KCl should be avoided; alternatives include liquid or effervescent potassium preparations."@en ;
a dv:Drug-Drug-Interaction ;
rdfs:label "DDI between Trihexyphenidyl and Potassium Chloride - The ulcerative effects of solid oral dosage forms of KCl may be enhanced by Trihexyphenidyl, an anticholinergic. Anticholinergics slow gastric emptying, increasing the contact time between the gastrointestinal mucosa and KCl. Prolonged exposure to KCl increases the risk of gastric and intestinal irritation and ulceration. Solid oral dosage forms of KCl should be avoided; alternatives include liquid or effervescent potassium preparations. [drugbank_resource:DB00376_DB00761]"@en .
}